Abstract:Vascular calcification (VC) is a significant risk factor for cardiovascular morbidity and mortality. We recently reported that apocynin had benefits for preventing cardiovascular diseases. However, whether apocynin could attenuate VC is unknown. Here, we investigated the role of apocynin in VC and its underlying mechanisms. 163 participants with high or normal ankle-brachial index (ABI) were enrolled in this study for analyzing the demographic and biochemical data. In vitro, vascular smooth muscle cells (VSMCs) were exposed to calcification medium containing b-glycerophosphate and angiotensin II (Ang II) for 24 hours. The results showed that serum level of Ang II was significantly increased in patients with high ABI (P<0.05). In cultured VSMCs, Ang II significantly exacerbated osteogenic switching. The expression of osteogenic phenotype markers, including bone morphogenetic protein 2 (BMP2), runt-related transcription factor 2 (Runx2) and osteopontin (OPN), were significantly upregulated, whereas contractile markers expression, including alpha smooth muscle actin (a-SMA) and smooth muscle 22 alpha (SM22a) were simultaneously downregulated. However, these effects were greatly attenuated by apocynin. Apocynin enhanced expression of a-SMA by 5.3%, and reduced expression of BMP2, Runx2, OPN by 3.37%, 0.61% and 3.07%, respectively. Furthermore, extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation was upregulated by Ang II, and this effect was also reversed by apocynin. Intriguingly, pretreatment with U0126, an inhibitor of ERK1/2, had similar effects with apocynin. Apocynin may act as a novel molecular candidate to protect against VSMCs osteogenic switching through suppressing ERK1/2 pathway.

Apelin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells

Apelin-13 Promotes Late Endothelial Progenitor Cells Differentiation by Regulating Krüppel-like Factor 4.

Apelin Suppresses Apoptosis of Human Vascular Smooth Muscle Cells Via APJ/PI3-K/Akt Signaling Pathways

Apelin Stimulates Proliferation and Suppresses Apoptosis of Mouse Osteoblastic Cell Line MC3T3-E1 Via JNK and PI3-K/Akt Signaling Pathways.

Apelin Plays A Catabolic Role On Articular Cartilage: In Vivo And In Vitro Studies

Effect of apelin on human osteoblasts

Apelin Suppresses Apoptosis of Human Osteoblasts

Apelin-13 attenuates high glucose-induced calcification of MOVAS cells by regulating MAPKs and PI3K/AKT pathways and ROS-mediated signals

Apelin and Its Receptor Are Expressed in Human Osteoblasts

Apelin/APJ System: A Critical Regulator of Vascular Smooth Muscle Cell

Apelin Induces Vascular Smooth Muscle Cells Migration Via a PI3K/Akt/FoxO3a/MMP-2 Pathway.

Apelin–APJ Induces ICAM-1, VCAM-1 and MCP-1 Expression Via NF-κB/JNK Signal Pathway in Human Umbilical Vein Endothelial Cells

apelin-13 promotes proliferation of vascular smooth muscle cells by downregulating caveolae expression

Apocynin attenuates angiotensin II-induced vascular smooth muscle cells osteogenic switching via suppressing extracellular signal-regulated kinase 1/2.

Jagged-1/Notch3 Signaling Transduction Pathway is Involved in Apelin-13-induced Vascular Smooth Muscle Cells Proliferation.

Apelin-13 stimulation of VSMCs proliferation in rats

Apelin Attenuates TGF-β1-induced Epithelial to Mesenchymal Transition Via Activation of PKC-ε in Human Renal Tubular Epithelial Cells.

Apelin/APJ Signaling is a Critical Regulator of Statin Effects in Vascular Endothelial Cells--brief Report.

Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1.

Apelin-13 Increases Expression of ATP-binding Cassette Transporter A1 Via Activating Protein Kinase C Α Signaling in THP-1 Macrophage-Derived Foam Cells.

Adiponectin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells Through the Ampk/Mtor Pathway